Enero 2014
Mancera-Romero J, Hormigo-Pozo A, Fernández-Arquero J, Baca-Osorio A, Aparicio-Cervantes MJ, Muñoz-González L. [Use of glucose-lowering drugs in a primary care setting in Malaga during the years 2008-2012.]. Semergen. 2013 Nov 6. pii: S1138-3593(13)00192-5. doi: 10.1016/j.semerg.2013.09.004. [Epub ahead of print]
U.S. Preventive Services Task Force Screening for Gestational Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2014 Jan 14. doi: 10.7326/P14-9011. [Epub ahead of print]
Nwaneri C, Cooper H, Bowen-Jones D. Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis. Journal of Diabetes & Vascular Disease 2013;13(4) 192–207
Berkowitz SA, Meigs JB, Wexler DJ. Age at type 2 diabetes onset and glycaemic control: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2010. Diabetologia. 2013 Dec;56(12):2593-600. doi: 10.1007/s00125-013-3036-4. Epub 2013 Sep 1.
Chang SH1, Stoll CR1, Song J2, Varela JE3, Eagon CJ3, Colditz GA1 The Effectiveness and Risks of Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2003-2012. JAMA Surg. 2013 Dec 18. doi: 10.1001/jamasurg.2013.3654. [Epub ahead of print]
Mancera-Romero J, Hormigo-Pozo A, Fernández-Arquero J, Baca-Osorio A, Aparicio-Cervantes MJ, Muñoz-González L. [Use of glucose-lowering drugs in a primary care setting in Malaga during the years 2008-2012.]. Semergen. 2013 Nov 6. pii: S1138-3593(13)00192-5. doi: 10.1016/j.semerg.2013.09.004. [Epub ahead of print]
Febrero
Salas –Salvado J, et al. Prevention of Diabetes With Mediterranean Diets. A Subgroup Analysis of a Randomized Trial. Ann Intern Med. 2014;160:1-10.
Salas-Salvadó J,Bulló M, Babio N, Martínez-González MA, Ibarrola-Jurado N, Basora J, et al, For the PREDIMED Study investigators. Reduction in the Incidence of Type 2-Diabetes with the Mediterranean Diet: Results of the PREDIMED-Reus Nutrition Intervention Randomized Trial.Diabetes care 2010. Published online before print October 7, 2010
Egan AG1, Blind E, Dunder K, de Graeff PA, Hummer BT, Bourcier T, Rosebraugh C. Pancreatic safety of incretin-based drugs--FDA and EMA assessment. N Engl J Med. 2014 Feb 27;370(9):794-7. doi: 10.1056/NEJMp1314078
O'Connor LM, Lentjes MA, Luben RN, Khaw KT, Wareham NJ, Forouhi NG. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia. 2014 Feb 8. [Epub ahead of print]
Des Spence. Bad medicine: the way we manage diabetes BMJ 2013;346:f2695 doi: 10.1136/bmj.f2695 (Published 29 April 2013)
Jennings A, Welch AA, Spector T, Macgregor A, Cassidy A. Intakes of anthocyanins and flavones are associated with biomarkers of insulin resistance and inflammation in women. J Nutr. 2014 Feb;144(2):202-8. doi: 10.3945/jn.113.184358. Epub 2013 Dec 11.
Barshes NR, Sigireddi M, Wrobel JS, Mahankali A, Robbins JM, Kougias P, Armstrong DG.The system of care for the diabetic foot: objectives, outcomes, and opportunities. Diabet Foot Ankle. 2013 Oct 10;4. doi: 10.3402/dfa.v4i0.21847. eCollection 2013.
Marzo
The Emerging Risk Factors Collaboration. Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease. JAMA. 2014;311(12):1225-1233. doi:10.1001/jama.2014.1873.
Geller AI1, Shehab N1, Lovegrove MC1, Kegler SR2, Weidenbach KN3, Ryan GJ4, Budnitz DS1.National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations. JAMA Intern Med. 2014 Mar 10. doi: 10.1001/jamainternmed.2014.136. [Epub ahead of print]
Lee SJ. So Much Insulin, So Much Hypoglycemia. JAMA Intern Med. 2014 Mar 10. doi: 10.1001/jamainternmed.2013.13307. [Epub ahead of print]
Monami M, Dicembrini I, Mannucci E, Dipeptidyl peptidase-4 inhibitors and heart failure. A meta-analysis of randomized clinical trials., Nutrition, Metabolism and Cardiovascular. Diseases (2014), doi: 10.1016/j.numecd.2014.01.017.
Abril
Barquilla García A1, Llisterri Caro JL2, Prieto Díaz MA3, Alonso Moreno FJ4, García Matarín L5, Galgo Nafría A6, Mediavilla Bravo JJ7; en representación del Grupo de Trabajo de Hipertensión Arterial de la Sociedad Española de Médicos de Atención Primaria (Grupo HTA/SEMERGEN) y de los investigadores del Estudio PRESCAP 2010. [Blood pressure control in a population of hypertensive diabetic patients treated in primary care: PRESCAP-Diabetes Study 2010.] Semergen. 2014 Apr 2. pii: S1138-3593(14)00094-X. doi: 10.1016/j.semerg.2014.02.003. [Epub ahead of print]
Mayo
Junio
AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza® (saxagliptin)
Danaei G, García Rodríguez LA, Fernandez Cantero O, Hernán MA. Statins and Risk of Diabetes: An analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care. 2013 May;36(5):1236-40. doi: 10.2337/dc12-1756. Epub 2012 Dec 17.
Julio
Effects of dietary glycemic index on brain regions related to reward and craving in men.
Am J Clin Nutr. 2013 Jun 26. [Epub ahead of print]
Hill JO, Galloway JM, Goley A, Marrero DG, Minners R, Montgomery B, Peterson GE, Ratner RE, Sanchez E, Aroda VR. Scientific Statement: Socioecological Determinants of Prediabetes and Type 2 Diabetes. Diabetes Care. 2013 Jun 20. [Epub ahead of print]
Agosto
Schopman JE, Simon AC, Hoefnagel SJ, Hoekstra JB, Scholten RJ, Holleman F. The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2014 Jan;30(1):11-22. doi: 10.1002/dmrr.2470.
Diabetes Care. 2014 Jul;37(7):1786-8. doi: 10.2337/dc14-0500.
Sandbæk A, Griffin SJ, Sharp SJ, Simmons RK, Borch-Johnsen K, Rutten GE, van den Donk M, Wareham NJ, et al. Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study. Diabetes Care. 2014 Jul;37(7):2015-23. doi: 10.2337/dc13-1544. Epub 2014 May 1.
Richy FF, Sabidó-Espin M, Guedes S, Corvino FA, Gottwald-Hostalek U. Incidence of lactic acidosis in patients with type 2 diabetes with and without renal impairment treated with metformin: a retrospective cohort study. Diabetes Care. 2014 Aug;37(8):2291-5. doi: 10.2337/dc14-0464. Epub 2014 May 30.
Septiembre
Margolis DJ1, Hoffstad O2, Weibe DJ2. Lower-extremity amputation risk is associated with variation in behavioral risk factor surveillance system responses. Diabetes Care. 2014 Aug;37(8):2296-301. doi: 10.2337/dc14-0788. Epub 2014 May 30.
Li Y, Hu Y, Ley SH, Rajpathak S, Hu FB. Sulfonylurea Use and Incident Cardiovascular Disease Among Patients With Type 2 Diabetes: Prospective Cohort Study Among Women.
Diabetes Care. 2014 Aug 22. pii: DC_141306. [Epub ahead of print]
Balkau B, Home PD, Vincent M, Marre M, Freemantle N..Factors associated with weight gain in people with type 2 diabetes starting on insulin. Diabetes Care. 2014 Aug;37(8):2108-13. doi: 10.2337/dc13-3010. Epub 2014 May 13.
Vijan S, Sussman JB, Yudkin JS, Hayward RA. Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus. JAMA Intern Med. 2014 Aug 1;174(8):1227-34. doi: 10.1001/jamainternmed.2014.2894.
Feinman RD,Pogozelski WK, Astrup A, Bernstein RK, Fine EJ,Westman EC, MD, et al. Dietary Carbohydrate restriction as the first approach in diabetes management. Critical review and evidence base. NUT-D-14-00247_DM_Evidence_REV.doc
Octubre
Salas –Salvado J, et al. Prevention of Diabetes With Mediterranean Diets. A Subgroup Analysis of a Randomized Trial. Ann Intern Med. 2014;160:1-10.
Pascual de la Pisa B, Márquez Calzada C, Cuberos Sánchez C, Cruces Jiménez JM, Fernández Gamaza M, Martínez Martínez MI; en representación de los investigadores del estudio DESIDIAB 1. [Compliance with process indicators in people with type 2 diabetes and linking incentives in Primary Care.] [Article in Spanish], Aten Primaria. 2014 Jun 26. pii: S0212-6567(14)00179-6. doi: 10.1016/j.aprim.2014.05.004. [Epub ahead of print]
La combinación de insulina basal y agonistas de los receptores incretínicos. Eng C, Kramer CK, Zinman B, Retnakaran R.Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis. Lancet. 2014 Sep 11. pii: S0140-6736(14)61335-0. doi: 10.1016/S0140-6736(14)61335-0. [Epub ahead of print]
Noviembre
Selvin E, Lazo M, Chen Y, Shen L, Rubin J, McEvoy JW, et al. Diabetes mellitus, prediabetes, and incidence of subclinical myocardial damage. Circulation. 2014 Oct 14;130(16):1374-82. doi: 10.1161/CIRCULATIONAHA.114.010815.
Diciembre